Trial Profile
Phase II Trial of Low Dose Decitabine (Dacogen) in Patients With Primary Myelofibrosis and Post ET/PV Myelofibrosis.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Decitabine (Primary)
- Indications Myelofibrosis
- Focus Therapeutic Use
- 30 Mar 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 07 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Apr 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov.